Condition: Acute Ischemic Stroke · Sponsor: University Hospital, Montpellier
Our main hypothesis is that acute EVT associated with best medical treatment is superior to best medical treatment alone, for improving clinical outcomes at 90 days, in patients with mild or severe acute ischemique stroke and diffusion-perfusion or clinical-imaging mismatch, secondary to CICAO.
This description comes directly from the study's public registry record.
Caroline ARQUIZAN, Medical Doctor · 0033467330204 · c-arquizan@chu-montpellier.fr
COSTALAT Vincent, Medical Doctor · 0033467337532 · v-costalat@chu-montpellier.fr
Always discuss trial participation with your own doctor first.
| Department of Neurology/ Stroke Unit, Hôpital Gui de Chauliac | Montpellier, Fance, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05832762